Skip to content
10-Q

Quarterly Report

BIOXYTRAN, INC. BIXT

0001641172-25-010822

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 15, 2025 88.99M sh
Short Term Debt Q1 2025 · Mar 31, 2025 $48K
Short Term Debt Q1 2025 · Dec 31, 2024 $48K
Current Liabilities Q1 2025 · Mar 31, 2025 $2.84M
Current Liabilities Q1 2025 · Dec 31, 2024 $1.93M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.84M
Total Liabilities Q1 2025 · Dec 31, 2024 $1.93M
Current Assets Q1 2025 · Mar 31, 2025 $4.35K
Current Assets Q1 2025 · Dec 31, 2024 $5.15K
Total Assets Q1 2025 · Mar 31, 2025 $136.05K
Total Assets Q1 2025 · Dec 31, 2024 $138.69K
Shares Diluted restated Q1 2025 · Mar 31, 2024 163.45M sh
Operating Cash Flow restated Q1 2025 · Mar 31, 2024 −$109.57K
Eps Diluted Q1 2025 · Mar 31, 2024 $0.00
Eps Basic Q1 2025 · Mar 31, 2024 $0.00
Rd Expense Q1 2025 · Mar 31, 2024 $27K
Net Income restated Q1 2025 · Mar 31, 2024 −$560.52K
Operating Income restated Q1 2025 · Mar 31, 2024 −$779.23K